SCHEMBL67250

SCHEMBL67250

Cc1ccc(C(O)C(=O)c2ccc(N(C)C)cc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.73
KDM4E B2RXH2 3/20 0.73
TSHR P16473 2/20 0.70
HSD17B10 Q99714 1/20 0.70
MAPT P10636 2/20 0.48
HPGD P15428 2/20 0.48
HTT P42858 1/20 0.48
CES2 O00748 2/20 0.47
CES1 P23141 2/20 0.47
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20943429 0.93 ALDH1A1 (0.83) ALDH1A1KDM4ETSHRHSD17B10MAPT
SCHEMBL66875 0.88 CES2 (0.58) ALDH1A1KDM4ETSHRHSD17B10HPGD
SCHEMBL29247977 0.85 ALDH1A1 (0.71) ALDH1A1KDM4ETSHRHSD17B10MAPT
SCHEMBL11279438 0.85 ALDH1A1 (0.71) ALDH1A1KDM4ETSHRHSD17B10MAPT
SCHEMBL11279441 0.85 ALDH1A1 (0.71) ALDH1A1KDM4ETSHRHSD17B10MAPT
SCHEMBL67861 0.85 ALDH1A1 (1.00) ALDH1A1KDM4ETSHRHSD17B10MAPT
SCHEMBL67860 0.85 ALDH1A1 (0.87) ALDH1A1KDM4ETSHRHSD17B10MAPT
SCHEMBL10909904 0.83 ALDH1A1 (0.68) ALDH1A1KDM4ETSHRHSD17B10MAPT
SCHEMBL10909899 0.83 ALDH1A1 (0.68) ALDH1A1KDM4ETSHRHSD17B10MAPT
SCHEMBL11623531 0.79 CES2 (0.50) ALDH1A1KDM4ETSHRHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129087-B2 Block copolymer and substrate processing method CANON KABUSHIKI KAISHA (JP) 2012-03-06 US disclosed
US-7776509-B2 Photosensitive compound, photosensitive composition, resist pattern forming method, and device production process CANON KABUSHIKI KAISHA (JP) 2010-08-17 US disclosed
US-20090311637-A1 BLOCK COPOLYMER AND SUBSTRATE PROCESSING METHOD CANON KABUSHIKI KAISHA (JP) 2009-12-17 US disclosed
EP-1956429-A1 Photosensitive compound, photosensitive composition, resist pattern forming method, and device production process Canon Kabushiki Kaisha (JP) 2008-08-13 EP disclosed
US-20080187865-A1 PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS CANON KABUSHIKI KAISHA (JP) 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080187865-A1 PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS FRG1, TYR, RER1 ALDH1A1 2014/4885KDM4E 1931/4885TSHR 2121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.